Published • loading... • Updated
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $155.00
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $155.00
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price target raised by investment analysts at Royal Bank Of Canada from $135.00 to $155.00 in a report released on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target indicates a potential upside of 96.13% from […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
